HULEX | RMFCX | HULEX / RMFCX | |
Total Expense Ratio | 1.00 | 0.91 | 110% |
Annual Report Gross Expense Ratio | 1.03 | 0.91 | 113% |
Fund Existence | 14 years | 23 years | - |
Gain YTD | 7.742 | 11.292 | 69% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 415M | 109B | 0% |
Annual Yield % from dividends | 1.15 | 1.24 | 93% |
Returns for 1 year | 13.30 | 8.71 | 153% |
Returns for 3 years | 48.48 | 28.01 | 173% |
Returns for 5 years | 111.60 | 56.72 | 197% |
Returns for 10 years | 205.01 | 92.34 | 222% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
WDNA | 14.64 | 0.17 | +1.16% |
WisdomTree BioRevolution ETF | |||
BKEM | 70.26 | 0.64 | +0.92% |
BNY Mellon Emerging Markets Equity ETF | |||
SPBU | 26.97 | 0.09 | +0.33% |
AllianzIM Buffer15 Uncapped Allc ETF | |||
IMTB | 44.31 | 0.13 | +0.28% |
iShares Core 5-10 Year USD Bond ETF | |||
IBTI | 22.42 | 0.01 | +0.04% |
iShares iBonds Dec 2028 Term Treasury ETF |